Tag | Content |
---|
EnhancerAtlas ID | HS047-00251 |
Organism | Homo sapiens |
Tissue/cell | Fetal_placenta |
Coordinate | chr1:11967760-11970280 |
SNPs | Number: 1 | ID | Chromosome | Position | Genome Version |
|
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
Nkx3-2 | MA0122.3 | chr1:11968331-11968344 | TTTAAGTGTTTTA | - | 6.33 | ZNF143 | MA0088.2 | chr1:11967995-11968011 | TACCCACAATGCATTG | + | 9.63 | ZNF143 | MA0088.2 | chr1:11970183-11970199 | CAATGCATTGTGGGTA | - | 9.63 | Zfx | MA0146.2 | chr1:11969285-11969299 | GAGGCCGAGGCGGG | - | 6.01 |
|
| Number of super-enhancer constituents: 23 | ID | Coordinate | Tissue/cell |
SE_04401 | chr1:11967802-11970392 | Brain_Anterior_Caudate | SE_05426 | chr1:11967459-11970702 | Brain_Cingulate_Gyrus | SE_06308 | chr1:11966827-11970789 | Brain_Hippocampus_Middle | SE_07453 | chr1:11967402-11970810 | Brain_Hippocampus_Middle_150 | SE_08423 | chr1:11967438-11970628 | Brain_Inferior_Temporal_Lobe | SE_10739 | chr1:11967490-11970531 | CD19_Primary | SE_13010 | chr1:11967686-11969397 | CD34_Primary_RO01480 | SE_13010 | chr1:11969509-11970356 | CD34_Primary_RO01480 | SE_13630 | chr1:11967645-11970731 | CD34_Primary_RO01536 | SE_14236 | chr1:11967710-11969205 | CD34_Primary_RO01549 | SE_14236 | chr1:11969377-11970343 | CD34_Primary_RO01549 | SE_14675 | chr1:11967367-11971255 | CD4_Memory_Primary_7pool | SE_16078 | chr1:11967699-11970381 | CD4_Naive_Primary_7pool | SE_16518 | chr1:11967714-11970388 | CD4_Naive_Primary_8pool | SE_21206 | chr1:11967365-11970416 | CD8_Memory_7pool | SE_21842 | chr1:11967413-11970668 | CD8_Naive_7pool | SE_22216 | chr1:11967346-11970790 | CD8_Naive_8pool | SE_34570 | chr1:11966817-11970548 | HCT-116 | SE_40308 | chr1:11967553-11971272 | K562 | SE_54351 | chr1:11967622-11970499 | Spleen | SE_66899 | chr1:11967081-11970418 | H2171 | SE_67244 | chr1:11967631-11970544 | MM1S | SE_67657 | chr1:11967812-11970390 | u87 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr1 | 11968510 | 11969143 | chr1 | 11967830 | 11968200 |
|
Enhancer Sequence | CTTATTAGGC TAATTGTGCA ATTAAAAAAA AAAAAAAATT GCAAAAACCG CAATTACTTT 60 TGCACCGATC TAATAGCTCG CCCACTGTAA GTAAAGCAGG TAAAGTCAGC CTTTTTCTTC 120 TGGGACCAGA CTCTGCTCTG CCCCGCGGTG GTGGCCTCAG GCGCAGCGCT AAAACGCATG 180 AACCATTTAA GGTATTTCCT GAAACTGGAG CGTGATTGGT GAGACTTTAT TTGCATACCC 240 ACAATGCATT GCGCACTAAA TAATGTTCGT CTTTAAAATT ATTTCCCCTT TTTCCTTCAA 300 CATATCTTTC TCGGAACCGA GATTGCTGTC CCAGAATTGT CTGAAGAAAA AGGCTGAAGT 360 CAATAGCTCT TTTGGGCCGA AGGAAAGTTA CCATTACCCG TTTAGGAGTA GCCGTTACCT 420 GAGAACTGTA GTGTCGACGA CTGATGTTAT ACTCTGGTTT CTCTTCAAAT CGTATAAATC 480 TTTCGCCTTT TACTAAAGAT TTCCGTGGAG AGAAACGAGT GTGAGTCTGA AACCAATTTT 540 TTGAGGCCTT GCGTTTCTTA GCAGGGCTTA TTTTAAGTGT TTTAAAAACA GATGCGATTC 600 CGTTAAATCG CGTGTGGAGC TATGTAAAGT GTATTATAGA ACAAATGCGA GTTACGGTTT 660 TTCAGCTTTT CGCTTTGTTA AGGTATGTGA TATCAATTGT ATTGCATTTC TGAGCAGTTA 720 TAATATTAAG ATGTTGGGGT GGCTTACTGC TTTTGACCAA GAAGTAGGGT TTGTTGGTTG 780 ATTACACCAG TGGTTTTTAA CCCCAGCCAC TGAGTGATGG AGGGTTACCG ACTCACAAGC 840 GAGCATTAAC GCCTGAGGTC CGCCTGCTGT CAGGGCAGCA AGGCATCAGA TTCTCCTAGG 900 AGCGGGAACC CTATTGTGAA CTGCGTATAC GAGGTATCTA GGTGCGTGCT CCTTTTAAGA 960 ATCTAATGGC TGATGACGAG GGGCACAGTT TCAACCTGGA ACTGTCCACA CCCCCTACCC 1020 ACCTTCCCCC GCCCTTGGAA AAACTGCCTT CCATGAACTG GGTCCCTTGT GCCAGAAAGG 1080 TTGGGGACCG CTGGACTATC CGATCAAATG AAGCAGGGAC TCGGGGCGAG CTCCCCCGCT 1140 GCTCCCGCCG GCTTCTCCGT GTAGAATCGA AGAAGGCAGT CCCAAGGGCT CTTCTGCCCC 1200 GTATCCCCGC CTGAGGAGCG TGCCAGGCGC GCAGCTAGTC CTCCCCCGAC CCAACCGGTT 1260 TGATGAAACG CAAGAGAAAG TGAATTTTCC AGCCACTCCC ATTGGCCAGA ATTCGTCTCA 1320 GCCGCAAGGG AGGCTGGGAA GTGCAGTCAT GCCTTCAGGT AGCCGTGAGC CCTGCTAGCG 1380 ATAGGAGATT CTAGAGAGAG GTTGAGTACT GGGGAGGAAA AACTAGCAGG GTCTGTCCCA 1440 GTAAAGGAGG GAGGAAATCC ATCGCAAAAA ATCCTGACCC CCAGGCCGGG CGCGGTGGCT 1500 CACGCCTGTA ATCCCAGCAC TTTGGGAGGC CGAGGCGGGC GGATCACCTG CGGATCACCT 1560 GAGGTCAGGA GTTCGAGACT GGCCTGGCCA ACATGGAGAA ACCCCGTCTC TACTAAAAAT 1620 ACAAAAATTA GCCGGGCAGG AGGGCGCATG CCTGTAATCA CAGCCACTCG GGAGGCTGAG 1680 GCAGGAGAAT CGCTTGAACC TGGAAGGCGG AGGTTGCAGT GAACCGAGAT CGCGCCACTG 1740 CACTCGATCC TGAGCGACAG AGCGAGACTC TGTCTCAAAA AAAAAAAAAA AAAAAAAAAA 1800 AAATCTACCC CGGGCTCAGG CCCTGAAGCA GCCGCCCACA GCCCAGCCCC GCCGTGCCCC 1860 GCCGTGCCCC GCCGTGCCCC GCCGTGCCCC GCCATGCGAC TCAAAGCCCC ATTCAAGCTA 1920 CGTAGGAGGG TAAATTGTCC TTTTCCCCCA AGGCCAGCTG CTCCTCCAGA AGCCAGCTCT 1980 GGTCCTTCAG ACTCAAATAC TAGGGAACAA TGTTTTCTCT GAGTTTTGAG TGTGTTTCTT 2040 GTTTCAGAGT AAATACGAAC CGTCGTAATG GCTAAGGGCA TCTACTTTTA AAACGCTCAA 2100 ATAAGCCTTG CTAAAAAATG CAAGACCTCT AAAAAATTGG TTTAAAACTC AGAATTATTC 2160 CTCTCCACGG AAATCTTTAG TAAAAGGCGA AAGATTTATG CGATATGAAG AGAAACTAGA 2220 GTAAGAACTT CGATGAGTGG CACTCAGTTC TCAGGTAATG GCTACTCCCA ACAGGCTAAT 2280 GGTAAATTTC TTTCTGCCCA AAAGAGCTAT TGACTTCTGC CTTTTTCTTC AGACAATTCT 2340 GGAACAGCAA TCTCAGTTTC AGGAAAGATA GATTGAAGGA AAAAGGGGAC TAGTAATTTT 2400 AAAGACGAAA ATTATTTGGT GCACAATGCA TTGTGGGTAT GCAAATAAAG TCTCAGCAAT 2460 CAAGCTCCAA TTTTGACAAA CTGGTGAAGC CTTAGGGACT CCTCAAAAAA AGGTTTTCTG 2520
|